Skip to Content
 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Breast Cancer

    Enzyme affects tumor metastasis

    Thursday, January 8th, 2015

    Breast cancer remains the most common type of cancer in females, with survival rates decreasing sharply for those with distant metastases. MMP2, a type of enzyme that degrades the extracellular matrix, has previously been implicated in the development of distant tumor metastases, but without a clearly defined role. In the Journal of Pathology, Barbara Fingleton, […]

    Combo therapy may help fight melanoma

    Thursday, January 8th, 2015

    Two therapies already in clinical development as single agents may work in combination to treat many subtypes of melanoma, a recent study suggests.

    Gene linked to breast cancer therapy response

    Friday, November 21st, 2014

    A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. The study was published online in the Journal of Clinical Investigation. Luis Schwarz, M.D., and Emily Fox, Ph.D., served as co-first authors of the study, led by senior author Carlos […]

    More breast cancer patients choose mastectomy

    Friday, November 21st, 2014

    Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that is confined to one breast, a Vanderbilt study shows.

    New Insights on Postpartum Breast Cancer

    Friday, October 31st, 2014

    A new study explaining the cellular activity that leads to breast tumor metastasis among women who have recently given birth may offer new treatment direction for postpartum breast cancer.

    VICC Investigators Earn Breast Cancer Grants

    Thursday, October 23rd, 2014

    Three Vanderbilt-Ingram Cancer Center (VICC) investigators have been awarded breast cancer research grants totaling $830,000 from the Susan G. Komen organization.

    Study Seeks to Improve Lymphedema Care

    Thursday, October 16th, 2014

    A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.

    Limiting Breast Cancer Metastasis

    Thursday, August 28th, 2014

    Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.

    New target for breast cancer therapy

    Monday, August 4th, 2014

    by Leigh MacMillan The protein MTBP is important for growth and survival of triple negative breast cancer (TNBC) – a clinically aggressive subtype of breast cancer that is commonly resistant to targeted therapeutics – Vanderbilt investigators have discovered. Using data from The Cancer Genome Atlas, Christine Eischen, Ph.D., MSTP student Brian Grieb, Ph.D., and colleagues […]

    Komen breast cancer research grants

    Friday, August 1st, 2014

    by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]

    Next Page »« Previous Page

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us